Pharmaceutical Preparations · DE · CIK 1701108
Develops novel treatments for multi-drug-resistant bacterial infections and rare diseases
Comparable business profile · signals at a glance
In the 90 days to Feb 6, 2026: 2 sold $393K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 6, 2026 | Rajavelu EstherSee Remarks | Sell | 50,816 | $2.36 | $120K |
| Feb 6, 2026 | Rajavelu EstherSee Remarks | Sell | 37,101 | $2.36 | $88K |
| Feb 6, 2026 | Keutzer TimothyChief Operating Officer | Sell | 18,652 | $2.36 | $44K |
| Feb 4, 2026 | Keutzer TimothyChief Operating Officer | Sell | 3,471 | $2.24 | $8K |
| Feb 3, 2026 | Keutzer TimothyChief Operating Officer | Sell | 24,224 | $2.14 | $52K |
| Feb 2, 2026 | Keutzer TimothyChief Operating Officer | Sell | 18,891 | $2.20 | $42K |
| Feb 2, 2026 | Rajavelu EstherSee Remarks | Sell | 18,442 | $2.20 | $41K |
| Nov 7, 2025 | Rajavelu EstherSee Remarks | Sell | 40,270 | $2.37 | $95K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.